Telerehabilitation of acute musculoskeletal multi-disorders: prospective, single-arm, interventional study.

Digital therapy Home-based digital rehabilitation Musculoskeletal pain Physical therapy Rehabilitation eHealth

Journal

BMC musculoskeletal disorders
ISSN: 1471-2474
Titre abrégé: BMC Musculoskelet Disord
Pays: England
ID NLM: 100968565

Informations de publication

Date de publication:
04 Jan 2022
Historique:
received: 03 08 2021
accepted: 18 11 2021
entrez: 5 1 2022
pubmed: 6 1 2022
medline: 7 1 2022
Statut: epublish

Résumé

Acute musculoskeletal (MSK) pain is very common and associated with impaired productivity and high economic burden. Access to timely and personalized, evidence-based care is key to improve outcomes while reducing healthcare expenditure. Digital interventions can facilitate access and ensure care scalability. Present the feasibility and results of a fully remote digital care program (DCP) for acute MSK conditions affecting several body areas. Interventional single-arm study of individuals applying for digital care programs for acute MSK pain. Primary outcome was the mean change between baseline and end-of-program in self-reported Numerical Pain Rating Scale (NPRS) score and secondary outcomes were change in analgesic consumption, intention to undergo surgery, anxiety (GAD-7), depression (PHQ-9), fear-avoidance beliefs (FABQ-PA), work productivity (WPAI-GH) and engagement. Three hundred forty-three patients started the program, of which 300 (87.5%) completed the program. Latent growth curve analysis (LGCA) revealed that changes in NPRS between baseline and end-of-program were both statistically (p < 0.001) and clinically significant: 64.3% reduction (mean - 2.9 points). Marked improvements were also noted in all secondary outcomes: 82% reduction in medication intake, 63% reduction in surgery intent, 40% in fear-avoidance beliefs, 54% in anxiety, 58% in depression and 79% recovery in overall productivity. All outcomes had steeper improvements in the first 4 weeks, which paralleled higher engagement in this period (3.6 vs 3.2 overall weekly sessions, p < 0.001). Mean patient satisfaction score was 8.7/10 (SD 1.26). This is the first longitudinal study demonstrating the feasibility of a DCP for patients with acute MSK conditions involving several body areas. Major strengths of this study are the large sample size, the wide range of MSK conditions studied, the breadth of outcomes measured, and the very high retention rate and adherence level. The major limitation regards to the absence of a control group. We observed very high completion and engagement rates, as well as clinically relevant changes in all health-related outcomes and productivity recovery. We believe this DCP holds great potential in the delivery of effective and scalable MSK care. NCT, NCT04092946 . Registered 17/09/2019.

Sections du résumé

BACKGROUND BACKGROUND
Acute musculoskeletal (MSK) pain is very common and associated with impaired productivity and high economic burden. Access to timely and personalized, evidence-based care is key to improve outcomes while reducing healthcare expenditure. Digital interventions can facilitate access and ensure care scalability.
OBJECTIVE OBJECTIVE
Present the feasibility and results of a fully remote digital care program (DCP) for acute MSK conditions affecting several body areas.
METHODS METHODS
Interventional single-arm study of individuals applying for digital care programs for acute MSK pain. Primary outcome was the mean change between baseline and end-of-program in self-reported Numerical Pain Rating Scale (NPRS) score and secondary outcomes were change in analgesic consumption, intention to undergo surgery, anxiety (GAD-7), depression (PHQ-9), fear-avoidance beliefs (FABQ-PA), work productivity (WPAI-GH) and engagement.
RESULTS RESULTS
Three hundred forty-three patients started the program, of which 300 (87.5%) completed the program. Latent growth curve analysis (LGCA) revealed that changes in NPRS between baseline and end-of-program were both statistically (p < 0.001) and clinically significant: 64.3% reduction (mean - 2.9 points). Marked improvements were also noted in all secondary outcomes: 82% reduction in medication intake, 63% reduction in surgery intent, 40% in fear-avoidance beliefs, 54% in anxiety, 58% in depression and 79% recovery in overall productivity. All outcomes had steeper improvements in the first 4 weeks, which paralleled higher engagement in this period (3.6 vs 3.2 overall weekly sessions, p < 0.001). Mean patient satisfaction score was 8.7/10 (SD 1.26).
STRENGTHS AND LIMITATIONS UNASSIGNED
This is the first longitudinal study demonstrating the feasibility of a DCP for patients with acute MSK conditions involving several body areas. Major strengths of this study are the large sample size, the wide range of MSK conditions studied, the breadth of outcomes measured, and the very high retention rate and adherence level. The major limitation regards to the absence of a control group.
CONCLUSIONS CONCLUSIONS
We observed very high completion and engagement rates, as well as clinically relevant changes in all health-related outcomes and productivity recovery. We believe this DCP holds great potential in the delivery of effective and scalable MSK care.
TRIAL REGISTRATION BACKGROUND
NCT, NCT04092946 . Registered 17/09/2019.

Identifiants

pubmed: 34983488
doi: 10.1186/s12891-021-04891-5
pii: 10.1186/s12891-021-04891-5
pmc: PMC8728982
doi:

Banques de données

ClinicalTrials.gov
['NCT04092946']

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

29

Informations de copyright

© 2021. The Author(s).

Références

JMIR Rehabil Assist Technol. 2019 Feb 28;6(1):e13111
pubmed: 30816849
Musculoskelet Sci Pract. 2018 Apr;34:89-96
pubmed: 29414757
J Man Manip Ther. 2011 Nov;19(4):186-93
pubmed: 23115471
J Occup Environ Med. 2020 Nov;62(11):e651-e656
pubmed: 32941347
Am J Prev Med. 2016 Nov;51(5):833-842
pubmed: 27745683
J Orthop Trauma. 2019 May;33(5):e158-e182
pubmed: 30681429
BMC Musculoskelet Disord. 2008 Mar 19;9:36
pubmed: 18366679
World J Surg. 2020 Apr;44(4):1020-1025
pubmed: 30843100
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Ann Phys Rehabil Med. 2011 Jun;54(4):225-35
pubmed: 21531651
Curr Aging Sci. 2012 Feb;5(1):72-83
pubmed: 21762086
Br J Sports Med. 2019 May;53(9):554-559
pubmed: 29666064
Br J Sports Med. 2020 Jan;54(2):79-86
pubmed: 30826805
Am J Phys Med Rehabil. 2021 Apr 30;:
pubmed: 33935152
Hum Resour Health. 2017 Jan 23;15(1):8
pubmed: 28114960
Arthritis Care Res (Hoboken). 2010 Aug;62(8):1087-94
pubmed: 20235201
Clin Orthop Relat Res. 2014 Mar;472(3):883-91
pubmed: 24186468
Man Ther. 2010 Dec;15(6):514-21
pubmed: 20630793
Scand J Med Sci Sports. 1999 Apr;9(2):104-9
pubmed: 10220845
Am J Phys Med Rehabil. 2016 May;95(5):372-89
pubmed: 26945211
JMIR Rehabil Assist Technol. 2017 Dec 04;4(2):e11
pubmed: 29203460
J Pain. 2013 Oct;14(10):1019-30
pubmed: 23850095
J Occup Environ Med. 2012 Dec;54(12):1520-6
pubmed: 23114388
PM R. 2017 May;9(5S):S51-S58
pubmed: 28527504
J Affect Disord. 2020 Mar 15;265:395-401
pubmed: 32090765
Phys Ther. 2007 May;87(5):497-512
pubmed: 17374630
Am Fam Physician. 2012 Feb 15;85(4):343-50
pubmed: 22335313
Telemed J E Health. 2017 Feb;23(2):80-87
pubmed: 27529575
Scand J Public Health. 2021 Aug;49(6):589-597
pubmed: 31969068
JAMA Intern Med. 2021 Oct 1;181(10):1288-1296
pubmed: 34338710
Best Pract Res Clin Rheumatol. 2010 Apr;24(2):267-79
pubmed: 20227647
Br J Anaesth. 2010 Dec;105 Suppl 1:i69-85
pubmed: 21148657
Phys Ther. 2018 May 1;98(5):398-407
pubmed: 29669084
Curr Opin Psychol. 2015 Oct 1;5:24-30
pubmed: 25844393
JMIR Rehabil Assist Technol. 2019 Jun 21;6(1):e14523
pubmed: 31228176
Int J Occup Saf Ergon. 2015;21(4):480-5
pubmed: 26694000
Spine (Phila Pa 1976). 2005 Jun 1;30(11):1331-4
pubmed: 15928561
Sci Rep. 2018 Jul 26;8(1):11299
pubmed: 30050087
Scand J Work Environ Health. 2019 Jan 1;45(1):42-52
pubmed: 30132008
J Rehabil Med. 2014 Feb;46(2):153-8
pubmed: 24322559
PLoS One. 2018 Sep 24;13(9):e0204311
pubmed: 30248127
Aust J Physiother. 2008;54(1):7-20
pubmed: 18298355
Lancet. 2011 Oct 29;378(9802):1560-71
pubmed: 21963002
Curr Opin Anaesthesiol. 2011 Oct;24(5):545-50
pubmed: 21772141
Am J Phys Med Rehabil. 2021 Mar 1;100(3):280-287
pubmed: 33595941
J Telemed Telecare. 2017 Feb;23(2):239-247
pubmed: 26940798
Med Care. 2004 Dec;42(12):1194-201
pubmed: 15550799
Am J Phys Med Rehabil. 2019 Oct;98(10):850-858
pubmed: 31021823
J Exerc Rehabil. 2019 Apr 26;15(2):193-199
pubmed: 31111000
J Rehabil Med. 2003 May;35(3):132-40
pubmed: 12809196
Pharmacoeconomics. 1993 Nov;4(5):353-65
pubmed: 10146874
J Bone Joint Surg Am. 2011 Jan 19;93(2):113-20
pubmed: 21248209
Physiotherapy. 2018 Sep;104(3):277-298
pubmed: 30030037
Clin J Pain. 2012 Oct;28(8):658-66
pubmed: 22510537
J Med Internet Res. 2017 Apr 28;19(4):e142
pubmed: 28455277
Arthritis Rheum. 2006 Oct;54(10):3212-20
pubmed: 17009255
J Orthop Sports Phys Ther. 1996 May;23(5):332-6
pubmed: 8728532
Ther Adv Musculoskelet Dis. 2021 Feb 26;13:1759720X21995067
pubmed: 33737965
J Bone Joint Surg Am. 2015 Jul 15;97(14):1129-41
pubmed: 26178888
Pain Manag. 2020 Nov;10(6):421-436
pubmed: 33111634
J Occup Rehabil. 2018 Sep;28(3):559-567
pubmed: 29236203
Man Ther. 2010 Jun;15(3):220-8
pubmed: 20163979
Disabil Rehabil. 2013 Aug;35(18):1564-70
pubmed: 23009191
Disabil Rehabil. 2017 Mar;39(6):519-534
pubmed: 27097761
Trials. 2020 Jul 6;21(1):615
pubmed: 32631400
J Sport Rehabil. 2011 Feb;20(1):115-28
pubmed: 21411827
Healthcare (Basel). 2018 May 17;6(2):
pubmed: 29772754
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941
Mil Med. 2012 Sep;177(9):1075-80
pubmed: 23025138
Best Pract Res Clin Rheumatol. 2007 Feb;21(1):77-91
pubmed: 17350545
Cochrane Database Syst Rev. 2010 Jan 20;(1):CD005956
pubmed: 20091582
J Med Internet Res. 2020 May 11;22(5):e18250
pubmed: 32208358
Braz J Phys Ther. 2015 Jul-Aug;19(4):251-7
pubmed: 26443971
Arch Orthop Trauma Surg. 2013 Aug;133(8):1129-41
pubmed: 23712708
Musculoskeletal Care. 2018 Mar;16(1):233-237
pubmed: 28401666

Auteurs

Fabíola Costa (F)

SWORD Health Technologies, Inc, Draper, UT, USA.

Dora Janela (D)

SWORD Health Technologies, Inc, Draper, UT, USA.

Maria Molinos (M)

SWORD Health Technologies, Inc, Draper, UT, USA.

Jorge Lains (J)

Rovisco Pais Medical and Rehabilitation Centre, Tocha, Portugal.
Faculty of Medicine, Coimbra University, Coimbra, Portugal.

Gerard E Francisco (GE)

Department of Physical Medicine and Rehabilitation, The University of Texas Health Science Center McGovern Medical School, and TIRR Memorial Hermann, Houston, TX, USA.

Virgílio Bento (V)

SWORD Health Technologies, Inc, Draper, UT, USA.

Fernando Dias Correia (F)

SWORD Health Technologies, Inc, Draper, UT, USA. fcorreia@swordhealth.com.
Neurology Department, Centro Hospitalar e Universitário do Porto, Porto, Portugal. fcorreia@swordhealth.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH